EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Investigating the altered expression of miR ‐486‐5p and miR ‐novel‐chr1_40444 in dysglycemia in a South African population

Cecil J Weale iD, Chanelle Schroeder, Don M Matshazi, Saarah Fg Davids, Rajiv T Erasmus, Andre P Kengne, Glenda M Davison, Tandi E Matsha

Journal of Diabetes Investigation · 2024

DOI: 10.1111/jdi.14278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2024. Verfasst von Cecil J Weale und 7 weiteren Autor:innen. Beteiligte Einrichtung: SAMRC/CPUT Cardiometabolic Health Research Unit, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula Universit…. Hauptthemen laut MEDLINE: MicroRNAs, Diabetes Mellitus, Type 2, Prediabetic State. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: South African Medical Research Council, National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aims to investigate miR‐486‐5p and miR‐novel‐chr1_40444 expressions in dysglycemic individuals. Validating RNA‐sequencing findings in a larger sample via reverse transcription qPCR (RT‐qPCR), we aim to address global diagnostic and screening limitations, using an African cohort as an example. Materials and Methods This cross‐sectional study involved 1,271 individuals [normoglycemic ( n = 974), prediabetic ( n = 206), screen‐detected type 2 diabetes ( n = 91)] from the ongoing Vascular and Metabolic Health (VMH) study in Cape Town, South Africa. Whole blood miRNA expression was assessed using TaqMan‐based RT‐qPCR, with data normalized to an endogenous control (miR‐16‐5p).

Results

Significant underexpression was observed in prediabetes vs normoglycemia for miR‐486‐5p ( P = 0.038), whilst both miRNAs demonstrated significant upregulation in screen‐detected type 2 diabetes vs normoglycemia (miR‐486‐5p, P = 0.009; miR‐novel‐chr1_40444, P < 0.001), and screen‐detected type 2 diabetes in comparison with prediabetes (miR‐486‐5p, P < 0.001; miR‐novel‐chr1_40444, P < 0.001). Multivariable regression analyses revealed pronounced interrelations between miR‐novel‐chr1_40444 and screen‐detected type 2 diabetes in unadjusted and adjusted models (Model 1: P < 0.001, Model 2: P < 0.001, Model 3: P = 0.030). Moreover, receiver operating characteristic (ROC) curves revealed significantly enhanced diagnostic capabilities for screen‐detected type 2 diabetes vs either normoglycemia (AUC = 0.971, P < 0.001), non‐diabetes (AUC = 0.959, P < 0.001), or prediabetes (AUC = 0.902, P < 0.001) when combining the miRNAs with 2 h postprandial glucose.

Conclusions

This study demonstrated the enhanced power of incorporating miRNAs with traditional markers in distinguishing screen‐detected type 2 diabetes, warranting further investigations on their unique role in the development of type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDiabetes Mellitus, Type 2Prediabetic StateHumansSouth AfricaMaleFemaleCross-Sectional StudiesMiddle AgedBiomarkersBlood GlucoseAdultAged

Stichwörter der Autor:innen

MicroRNAsSouth AfricaType 2 diabetes

Substanzen

MicroRNAsMIRN486 microRNA, humanBiomarkersBlood Glucose

Autor:innen und Institutionen

  • SAMRC/CPUT Cardiometabolic Health Research Unit, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Cape Town, South Africa.
  • Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University and National Health Laboratory Service, Cape Town, South Africa.
  • Non-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.
  • Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Department of Biological and Environmental Sciences, Faculty of Natural Sciences, Walter Sisulu University, Mthatha, South Africa.
  • Sefako Makgatho Health Sciences University (SMU), Pretoria, South Africa.

ORCID-Profile: Cecil J Weale

Förderung

  • South African Medical Research Council
  • National Research Foundation

Zitieren

APA

Weale, C. J., Schroeder, C., Matshazi, D. M., Davids, S. F., Erasmus, R. T., Kengne, A. P., Davison, G. M., & Matsha, T. E. (2024). Investigating the altered expression of miR ‐486‐5p and miR ‐novel‐chr1_40444 in dysglycemia in a South African population. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14278

Vancouver

Weale CJ, Schroeder C, Matshazi DM, Davids SF, Erasmus RT, Kengne AP, et al. Investigating the altered expression of miR ‐486‐5p and miR ‐novel‐chr1_40444 in dysglycemia in a South African population. Journal of Diabetes Investigation. 2024. doi:10.1111/jdi.14278

BibTeX
@article{Weale2024,
  author = {Weale, Cecil J and Schroeder, Chanelle and Matshazi, Don M and Davids, Saarah Fg and Erasmus, Rajiv T and Kengne, Andre P and Davison, Glenda M and Matsha, Tandi E},
  title = {Investigating the altered expression of miR ‐486‐5p and miR ‐novel‐chr1_40444 in dysglycemia in a South African population},
  journal = {Journal of Diabetes Investigation},
  year = {2024},
  doi = {10.1111/jdi.14278}
}
Kostenlos starten →